EP. 1: Dr. Rohs on Databases of Uncommon Mutations in NSCLC
Nicholas C. Rohs, MD, discusses databases of uncommon mutations in non–small cell lung cancer
EP. 2: Dr. Sabari on the Importance of Timely Testing for Uncommon Mutations in NSCLC
Joshua K. Sabari, MD, discusses the importance of timely testing for uncommon mutations in non–small cell lung cancer.
EP. 3: Dr. Aggarwal on Treating Patients With EGFR Mutations in NSCLC
Charu Aggarwal, MD, MPH, discusses treating patients with EGFR-mutant non–small cell lung cancer.
Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors
Navigating Systemic Therapy for RCC: Balancing Risk Status and Response
ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC
Precision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making
2 Clarke Drive Cranbury, NJ 08512